Vineet Laboratories Limited

NSEI:VINEETLAB Stock Report

Market Cap: ₹542.2m

Vineet Laboratories Past Earnings Performance

Past criteria checks 0/6

Vineet Laboratories's earnings have been declining at an average annual rate of -23.2%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 44.6% per year.

Key information

-23.2%

Earnings growth rate

-21.7%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate-44.6%
Return on equity-13.3%
Net Margin-3.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Vineet Laboratories (NSE:VINEETLAB) Seems To Be Using A Lot Of Debt

Jul 12
Vineet Laboratories (NSE:VINEETLAB) Seems To Be Using A Lot Of Debt

Earnings Working Against Vineet Laboratories Limited's (NSE:VINEETLAB) Share Price Following 25% Dive

Mar 07
Earnings Working Against Vineet Laboratories Limited's (NSE:VINEETLAB) Share Price Following 25% Dive

We Think Vineet Laboratories (NSE:VINEETLAB) Is Taking Some Risk With Its Debt

Feb 15
We Think Vineet Laboratories (NSE:VINEETLAB) Is Taking Some Risk With Its Debt

With EPS Growth And More, Vineet Laboratories (NSE:VINEETLAB) Makes An Interesting Case

Nov 14
With EPS Growth And More, Vineet Laboratories (NSE:VINEETLAB) Makes An Interesting Case

Revenue & Expenses Breakdown

How Vineet Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:VINEETLAB Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,134-41650
30 Jun 241,3771650
31 Mar 241,51010650
31 Dec 231,70827620
30 Sep 232,04961640
30 Jun 232,009-10620
31 Mar 232,12313610
31 Dec 222,10710560
30 Sep 221,82310470
30 Jun 221,82364460
31 Mar 221,91266580
31 Mar 212,43518560

Quality Earnings: VINEETLAB is currently unprofitable.

Growing Profit Margin: VINEETLAB is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VINEETLAB is unprofitable, and losses have increased over the past 5 years at a rate of 23.2% per year.

Accelerating Growth: Unable to compare VINEETLAB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VINEETLAB is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.4%).


Return on Equity

High ROE: VINEETLAB has a negative Return on Equity (-13.33%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 04:16
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vineet Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution